Company Uroclinic Dr. Haşegan S.r.l. with Fiscal Code 35547613
recorded a turnover of 2024 of
267.191,
with a net profit of
182.854
and having an average number of employees of
1.
The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Uroclinic Dr. Haşegan S.r.l.
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
-
47.386
127.773
127.331
156.847
180.294
173.171
196.581
263.354
267.191
Total Income - EUR
-
47.789
128.389
127.331
156.910
180.294
173.171
196.581
263.354
267.866
Total Expenses - EUR
-
15.983
30.491
31.015
34.014
29.025
42.833
46.536
63.752
76.995
Gross Profit/Loss - EUR
-
31.806
97.898
96.316
122.896
151.269
130.338
150.045
199.603
190.870
Net Profit/Loss - EUR
-
30.850
96.620
95.042
121.328
149.466
128.607
148.079
196.969
182.854
Employees
-
1
1
1
2
1
1
1
1
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 2.0%, from 263.354 euro in the year 2023, to 267.191 euro in 2024.
The Net Profit decreased by -13.014 euro, from 196.969 euro in 2023, to 182.854 in the last year.
Check the financial reports for the company - Uroclinic Dr. Haşegan S.r.l.
Financial Rating - UROCLINIC DR. HAŞEGAN S.R.L.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Uroclinic Dr. Haşegan S.r.l.
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Uroclinic Dr. Haşegan S.r.l.
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Uroclinic Dr. Haşegan S.r.l.
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Uroclinic Dr. Haşegan S.r.l. - CUI 35547613
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
-
14.349
16.025
30.588
35.377
38.895
31.927
73.841
56.604
67.910
Current Assets
-
19.038
97.098
107.904
17.796
139.583
132.217
95.029
157.001
248.395
Inventories
-
0
0
0
0
0
0
0
0
0
Receivables
-
514
5.010
494
0
0
19.657
89.034
89.224
110.530
Cash
-
18.525
92.088
107.409
17.795
139.583
112.560
5.995
67.777
137.866
Shareholders Funds
-
30.894
111.959
137.086
51.673
174.938
159.687
162.205
211.052
196.858
Social Capital
-
45
44
43
42
41
40
41
40
40
Debts
-
2.493
1.165
1.406
1.499
3.541
4.457
6.665
2.554
119.447
Income in Advance
-
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"8622 - 8622"
CAEN Financial Year
8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
248.395 euro in 2024 which includes Inventories of
0 euro, Receivables of
110.530 euro and cash availability of
137.866 euro.
The company's Equity was valued at
196.858 euro, while total Liabilities amounted to
119.447 euro.
Equity decreased by -13.014 euro, from 211.052 euro in 2023, to 196.858 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Uroclinic Dr. Haşegan S.r.l.